Perioperative Outcomes of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy in Patients with Diabetes Mellitus: an Analysis of the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) Database

  • 71 Accesses



The safety and efficacy of laparoscopic sleeve gastrectomy (LSG) and laparoscopic Roux-en-Y gastric bypass (LRYGB) to treat obesity and associated comorbidities, including diabetes mellitus, is well established. As diabetes may add risk to the perioperative period, we sought to characterize perioperative outcomes of these surgical procedures in diabetic patients.


Using the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) database, we identified patients who underwent LSG and LRYGB between 2015 and 2017, grouping by non-diabetics (NDM), non-insulin-dependent diabetics (NIDDM), and insulin-dependent diabetics (IDDM). Primary outcomes included serious adverse events, 30-day readmission, 30-day reoperation, and 30-day mortality. Univariate and multivariable analyses were used to evaluate the outcome in each diabetic cohort.


Multivariable analysis of patients who underwent LSG (with NDM patients as reference) showed higher 30-day mortality (NIDDM AOR = 1.52, p = 0.043; IDDM AOR = 1.91, p = 0.007) and risk of serious adverse events (NIDDM AOR = 1.15, p < 0.001; IDDM AOR = 1.58, p < 0.001) in the diabetic versus NDM groups. Multivariable analysis of patients who underwent LRYGB (with NDM patients as reference) showed higher risk of serious adverse events (NIDDM AOR = 1.09, p = 0.014; IDDM AOR = 1.43, p < 0.001) in the diabetic versus NDM groups.


Diabetics who underwent LSG and LRYGB had higher rates of several perioperative complications compared with non-diabetics. IDDM had a stronger association with several perioperative complications compared with NIDDM. This increase in morbidity and mortality is modest and should be weighed against the real benefits of bariatric surgery in patient with obesity and diabetes mellitus.

This is a preview of subscription content, log in to check access.

Access options

Buy single article

Instant unlimited access to the full article PDF.

US$ 39.95

Price includes VAT for USA

Subscribe to journal

Immediate online access to all issues from 2019. Subscription will auto renew annually.

US$ 99

This is the net price. Taxes to be calculated in checkout.


  1. 1.

    Centers for Disease Control and Prevention. Adult obesity facts. 2018. Available at: Accessed 01 Jun 2019.

  2. 2.

    Nickel F, Schmidt L, Bruckner T, et al. Influence of bariatric surgery on quality of life, body image, and general self-efficacy within 6 and 24 months – a prospective cohort study. Surg Obes Relat Dis. 2017;13(2):313–9.

  3. 3.

    Sjostrom L. Review of the key results from the Swedish Obese Subjects (SOS) trial – a prospective controlled intervention study of bariatric surgery. J Intern Med. 2012;273:219–34.

  4. 4.

    Yska JP, van Roon EN, de Boer A, et al. Remission of type 2 diabetes mellitus in patients after different types of bariatric surgery a population-based cohort study in the United Kingdom. JAMA Surg. 2015;150(12):1126–33.

  5. 5.

    Schauer DP, Arterburn DE, Livingston EH, et al. Impact of bariatric surgery on life expectancy in severely obese patients with diabetes: a decision analysis. Ann Surg. 2015;261(5):914–9.

  6. 6.

    Lin X, Li J, Chen W, et al. Diabetes and risk factors of anastomotic leakage after gastrointestinal surgery. J Surg Res. 2015;196(2):294–301.

  7. 7.

    Tao W, Plecka-Ostlund M, Lu Y, et al. Causes and risk factors for mortality within 1 year after obesity surgery in a population-based cohort study. Surg Obes Relat Dis. 2015;11(2):399–405.

  8. 8.

    Rawlins L, Rawlins MP, Brown CC, et al. Effect of elevated hemoglobin A1c in diabetic patients on complication rated after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2013;9(5):749–52.

  9. 9.

    Creange C, Sethi M, Fielding G, et al. The safety of laparoscopic sleeve gastrectomy among diabetic patients. Surg Endosc. 2017;31(2):907–911.10.

  10. 10.

    Ata A, Valerian BT, Lee EC, et al. The effect of diabetes mellitus on surgical site infections after colorectal and noncolorectal general surgical operations. Am Surg. 2010;76(7):697–702.

  11. 11.

    Serio S, Clements JM, Grauf D, et al. Outcomes of diabetic and nondiabetic patients undergoing general and vascular surgery. ISRN Surg. 2013;2013:963930.

  12. 12.

    Steele KE, Prokopowicz GP, Chang HY, et al. Risk of complications after bariatric surgery among individuals with and without type 2 diabetes mellitus. Surg Obes Relat Dis. 2012;8(3):305–30.

  13. 13.

    Centers for Disease Control and Prevention. New CDC report: more than 100 million Americans have diabetes or prediabetes. 2017. Available at: Accessed 4 June 2019.

  14. 14.

    Kizy S, Jahansouz C, Downey MC, et al. National trends in bariatric surgery 2012-2015: demographics, procedure selection, readmissions, and cost. Obes Surg. 2017;27(11):2933–9.

  15. 15.

    Sun S, Borisenko O, Spelman T, et al. Patient characteristics, procedural and safety outcomes of bariatric surgery in England: a retrospective cohort study-2006-2012. Obes Surg. 2018;28(4):1098–108.

  16. 16.

    Welbourn R, Pournaras DJ, Dixon J, et al. Bariatric surgery worldwide: baseline demographic description and one-year outcomes from the Second IFSO Global Registry Report 2013-2015. Obes Surg. 2018;28(2):313–22.

  17. 17.

    Scheen AJ, de Flines J, de Roover A, et al. Bariatric surgery in patients with type 2 diabetes: benefits, risks, indications and perspectives. Diabetes Metab. 2009;35(6 Pt 2):537–43.

  18. 18.

    Liakopoulos V, Franzén S, Svensson AM, et al. Pros and cons of gastric bypass surgery in individuals with obesity and type 2 diabetes: nationwide, matched, observational cohort study. BMJ Open. 2019;9(1):e023882.

  19. 19.

    Souteiro P, Belo S, Neves JS, et al. Preoperative beta cell function is predictive of diabetes remission after bariatric surgery. Obes Surg. 2017;27(2):288–94.

  20. 20.

    Hariri K, Guevara D, Jayaram A, et al. Preoperative insulin therapy as a marker for type 2 diabetes remission in obese patients after bariatric surgery. Surg Obes Relat Dis. 2018;14(3):332–7.

  21. 21.

    Vilarrasa N, Rubio MA, Miñambres I, et al. Long-term outcomes in patients with morbid obesity and type 1 diabetes undergoing bariatric surgery. Obes Surg. 2017;27(4):856–63.

  22. 22.

    Zaman JA, Shah N, Leverson GE, et al. The effects of optimal perioperative glucose control on morbidly obese patients undergoing bariatric surgery. Surg Endosc. 2017;31(3):1407–13.

  23. 23.

    Leonetti F, Campanile FC, Coccia F, et al. Very low-carbohydrate ketogenic diet before bariatric surgery: prospective evaluation of a sequential diet. Obes Surg. 2015;25(1):64–71.

Download references

Author information

Correspondence to Hassan Nasser.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Ethical Approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed Consent

For this type of study, formal consent is not required.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This paper has not been previously presented or submitted for publication.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Leonard-Murali, S., Nasser, H., Ivanics, T. et al. Perioperative Outcomes of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy in Patients with Diabetes Mellitus: an Analysis of the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) Database. OBES SURG 30, 111–118 (2020).

Download citation


  • Diabetes mellitus
  • Sleeve gastrectomy
  • Gastric bypass
  • Outcomes